Sage Journals: Discover world-class research

Retricted access

Research article

First published 2009-11

Off-Label Prescription of Antineoplastic Drugs: An Italian Prospective,Observational,Multicenter Survey

Fausto Roila, Enzo Ballatori, Roberto Labianca [...]

Tumori Journal

Retricted access

Research article

First published 2009-2

Paediatric status and off-label use of drugs in children in Italy,United Kingdom and the Netherlands

M. Sturkenboom, M. Felisi, C. Manfredi [...]

Pharmaceuticals Policy and Law

Retricted access

Research article

First published 2015-5

Off-Label Promotion of Prescription Medicine

Narcyz Ghinea, Wendy Lipworth, Ian Kerridge

Therapeutic Innovation & Regulatory Science

Open access

Research article

First published 2024-2

A guided framework for assessing off-label medication use in psychiatry

Kirk Lehman, Emeil Aroney

Australasian Psychiatry

Free access

Research article

First published 2018-10

Approved and Off-Label Use of Prescribed Psychotropic Medications among Federal Canadian Inmates

Gregory P. Brown, Lynn A. Stewart, Terry Rabinowitz [...]

The Canadian Journal of Psychiatry

Retricted access

Editorial

First published 2008-12

Data Supporting the Use of Prescription Medications for Off-Label Indications

Danial E. Baker

Hospital Pharmacy

Retricted access

Research article

First published 2013-7

Off-Label Prescription of Anticancer Drugs in Italy: What Responsibilities?

Jacopo Giuliani, Valentina Maiolli, Andrea Bonetti

Tumori Journal

Retricted access

Research article

First published 2020-4

The CJEU’s ruling in the Novartis Farma case: Money,health and medicines

Vera Lúcia Raposo

Maastricht Journal of European and Comparative Law

Retricted access

Research article

First published 2024-8

Research encouraging off-label use of quetiapine: A systematic meta-epidemiological analysis

Peter Grabitz, Lana Saksone, Susanne Gabriele Schorr [...]

Clinical Trials

Retricted access

Brief report

First published 2014-10

Off-Label Prescription of Genetically Modified Organism Medicines in Europe: Emerging Conflicts of Interest?

Frederik H.E. Schagen, Rob C. Hoeben, Geke A.P. Hospers

Human Gene Therapy

Search results